[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353173-105":59,"doc-detail-353173-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","psychological-distress-and-cancer-worry-in-unaffected-relatives-undergoing-cascade-testing-with-multigene-panel-testing","Psychological distress and cancer worry in unaffected relatives undergoing cascade testing with multigene panel testing","","Multigene panel testing (MGPT) is increasingly used to diagnose hereditary cancers, yet its effects in cascade testing remain unclear. This multicenter study in Japan enrolled 123 first-degree relatives without personal cancer history and assessed psychological responses before (T0) and two weeks after (T1) result disclosure. Clinically significant distress occurred in 6.5%, while higher baseline Cancer Worry Scale scores predicted elevated Impact of Event Scale–Revised distress after disclosure. Carriers showed higher distress, but results were not independently linked after adjustment, and overall cancer worry remained largely stable.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/psychological-distress-and-cancer-worry-in-unaffected-relatives-undergoing-cascade-testing-with-multigene-panel-testing/353173/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/psychological-distress-and-cancer-worry-in-unaffected-relatives-undergoing-cascade-testing-with-multigene-panel-testing/353173.png","ImageObject",300,407,{"name":92,"@type":93},"Aldword","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What psychological outcomes were measured in unaffected first-degree relatives after MGPT cascade testing?","Question",{"text":113,"@type":114},"Participants completed the Cancer Worry Scale (Japanese version, CWS-J) at T0 and T1, and the Impact of Event Scale–Revised (IES-R) at T1 to evaluate distress after result disclosure.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How common was clinically significant psychological distress two weeks after disclosure?",{"text":118,"@type":114},"Two weeks after disclosure, 6.5% of relatives met the threshold for clinically significant distress based on IES-R.",{"name":120,"@type":111,"acceptedAnswer":121},"What factor showed the strongest association with post-disclosure distress?",{"text":122,"@type":114},"Higher baseline CWS-J scores were strongly associated with elevated IES-R scores after disclosure (p \u003C 0.001).",{"name":124,"@type":111,"acceptedAnswer":125},"Did distress change overall from pre- to post-disclosure among relatives?",{"text":126,"@type":114},"CWS-J scores showed no significant change from pre- to post-disclosure, with 41% of relatives maintaining persistently high cancer worry.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},353173,1790249086,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":46,"preview_page_count":19,"preview_urls":149},2336478940917,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","[www.nature.com/jhg](www.nature.com/jhg)  \nARTICLE OPEN   \nPsychological distress and cancer worry in unaffected relatives undergoing cascade testing with multigene panel testing  \nKaori Kimura1, Takeshi Kuwata1 ✉ , Yumie Hiraoka1, Manami Matsukawa2, Chikako Tomozawa2, Miki Aitani 1, Yu Komura3, Izumi Miki1,3, Masashi Wakabayashi4, Yosuke Furui5, Hiroki Kondo5, Kazumasa Saigoh6, Yasuko Yamamoto 7, Kiwamu Akagi1,8, Hiroto Narimatsu9, Megumu Yokono 10, Shinsuke Amano 11, Kaori Muto12, Fuji Nagami13, Kazuto Kato 14, Riu Yamashita 15, Issei Imoto 16,  \nShinji Kosugi 17, Makoto Hirata 2, Takayuki Yoshino 18,19 and Yoshiaki Nakamura3,18  \n© The Author(s) 2026  \n\n|  |  |  |\n| --- | --- | --- |\n|  | Multigene panel testing (MGPT) is increasingly used for diagnosing hereditary cancers; however, its application in cascade testing remains limited, and the psychological impact on unaffected relatives is not well understood. This multicenter study in Japan recruited 123 ﬁrst-degree relatives without a personal history of cancer to evaluate psychological responses before (T0) and two weeks after (T1) MGPT result disclosure. Participants completed the Japanese version of the Cancer Worry Scale (CWS-J) at both time points and the Impact of Event Scale–Revised (IES-R) at T1 . Two weeks after disclosure, 6.5% of relatives met the threshold for clinically signiﬁcant distress. Mean IES-R scores were higher among carriers of pathogenic variants (mean 8.2) than among those with negative results (mean 4.8) or variants of uncertain signiﬁcance (mean 2.4) . In contrast, multivariate analysis revealed no independent association between test result and post-disclosure distress. In contrast, higher baseline CWS-J scores were strongly associated with elevated IES-R scores after disclosure (p \u003C 0.001) . Children and relatives who frequently discussed cancer risk within their families exhibited higher distress levels than other subgroups. Overall, CWS-J scores showed no signiﬁcant change from preto post-disclosure, with 41% of relatives maintaining persistently high worry. Across both time points, unaffected relatives consistently reported lower CWS-J scores than individuals with cancer (p \u003C 0.0001) . These ﬁndings suggest that MGPT has minimal psychological impact on unaffected relatives undergoing cascade testing, although those with higher preexisting cancer worry may |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  | require additional psychosocial support. |  |\n|  | Journal of Human Genetics (2026) 71:435–442; [https://doi.org/10.1038/s10038-026-01464-z](https://doi.org/10.1038/s10038-026-01464-z) |  |\n|  |  |  |\n\nINTRODUCTION  \nAs multigene panel testing (MGPT) is increasingly incorporated into clinical oncology [1], a clear understanding of its psychological impact on test recipients is essential. Prior studies indicate that relatives generally report lower levels of distress than probands [2], that cancer worry decrease among unaffected relatives following cascade testing [3], and that distress often rises immediately after result disclosure before decline over time [4] . Such psychological responses can inﬂuence screening behaviors [5] and quality of life [6] . The psychological effects of genetic testing are commonly measured using instruments such as the Cancer Worry Scale (CWS) [3, 7, 8], the Impact of Event Scale (IES)[2, 4], and the Multidimensional Impact of Cancer Risk Assessment (MICRA) [9–11] .  \nAlthough clinical uptake of MGPT varies by country [12–15], its use in affected probands is widespread, and in recent years, its application to cascade testing for relatives has been increasingly explored [16, 17] . Existing research on relatives has largely focused on those identiﬁed as carriers of germline pathogenic variants (GPVs) [2] or on single-site testing approaches [2, 3] . Moreover, most MGPT-related psychological research has targeted ","cbCaiftZ3vMA5NqH","https://ap.wps.com/l/cbCaiftZ3vMA5NqH","pdf",956863,"English","# Introduction\n## Study aim and psychological outcomes\n# Results\n## Distress thresholds and group comparisons\n## Predictors of post-disclosure distress","[{\"question\":\"What psychological outcomes were measured in unaffected first-degree relatives after MGPT cascade testing?\",\"answer\":\"Participants completed the Cancer Worry Scale (Japanese version, CWS-J) at T0 and T1, and the Impact of Event Scale–Revised (IES-R) at T1 to evaluate distress after result disclosure.\"},{\"question\":\"How common was clinically significant psychological distress two weeks after disclosure?\",\"answer\":\"Two weeks after disclosure, 6.5% of relatives met the threshold for clinically significant distress based on IES-R.\"},{\"question\":\"What factor showed the strongest association with post-disclosure distress?\",\"answer\":\"Higher baseline CWS-J scores were strongly associated with elevated IES-R scores after disclosure (p \\u003c 0.001).\"},{\"question\":\"Did distress change overall from pre- to post-disclosure among relatives?\",\"answer\":\"CWS-J scores showed no significant change from pre- to post-disclosure, with 41% of relatives maintaining persistently high cancer worry.\"}]","Psychological distress and cancer worry in unaffected relatives undergoing cascade testing with multigene panel testing | PDF",1790103417,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/46611eee28e697514a5c75c378f0d8b8.webp",983,1305,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f55607f3b7ca0817d0cc5481bfbf0d9a.webp",982,1304,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/863c6940b1f928a5a541d46d6098e47d.webp",981,1303,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c03008f2ba9b412004c5277ba171ec6.webp",980,1301]